NAT IVD Controls
Hematogenic screening criteria
1. Nucleic acid indoor quality NAT control products
|
Number |
Name |
Value of concentration |
Specifications |
|
|
Concentration |
Range of mean |
|||
|
GBDS-IQC-001 |
Hepatitis B virus DNA (HBV DNA) serum (liquid) indoor quality NAT control products
|
H (S4) |
1.00E+06～1.00E+07 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-002 |
M (S3) |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-003 |
L (S2) |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-004 |
Criticality (S1) |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-136 |
L1 |
500 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-137 |
L2 |
200 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-215 |
L3 |
100 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-138 |
L4 |
50 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-140 |
Hepatitis B virus DNA (HBV DNA) genotyping serum quality NAT control product |
Containing common HBV genotypes (B, C, D, Type B+C, etc.) |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-004-6 |
Hepatitis B virus drug resistance gene mutation serum (fluid Body) quality NAT control products |
Containing HBV YVDD, HBV YIDD and other genes |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-004-7 |
Hepatitis B virus DNA serum dried Disturbance material quality NAT control products |
Contains bilirubin, triglyceride, hemoglobin, Albumin, total IgG interfering substance and normal NAT control samples
|
0.5mL/ tube,12 tubes/kit |
|
|
GBDS-IQC-005 |
Hepatitis C virus RNA (HCV RNA) serum Indoor quality NAT control products
|
H (S3) |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-006 |
M (S2) |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-007 |
L (S1) |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-142 |
L1 |
500 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-143 |
L2 |
200 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-216 |
L3 |
100IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-146 |
Hepatitis C virus RNA (HCV RNA) Genotyping serum quality NAT control product |
Contains common HCV RNA genotypes (1a/1b/2a/6a/3a/3b)
|
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-007-5 |
Hepatitis C virus RNA serum interferometer Quality NAT control products |
Contains bilirubin, triglyceride, hemoglobin, Albumin, total IgG interfering substance and normal NAT control samples |
0.5mL/ tube,12tubes/kit |
|
|
GBDS-IQC-207-4 |
Hepatitis E virus RNA (HEV RNA) Plasma (liquid) indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC--207-3 |
M |
1.00E+04～1.00E+0 5 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC--207-2 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-150 |
Human immunodeficiency virus type 1 RNA (HIV-1 RNA) serum (liquid) indoor quality NAT control products |
H (S3) |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-151 |
M (S2) |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-152 |
L (S1) |
1.00E+02～1.00E+03IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-195 |
L1 |
1000IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-196 |
L2 |
500IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-197 |
L3 |
100IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-118 |
HBV DNA/HCV RNA Mix (liquid) quality NAT control products
|
H |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-119 |
M |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-120 |
L |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-223 |
HBV DNA/HCV RNA/HIV1 RNA Mix (liquid) quality NAT control products |
H |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-224 |
M |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-225 |
L |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-050 |
Epstein-barr virus DNA (EBV DNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-051 |
M |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-052 |
L |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-025 |
Human cytomegalovirus DNA (HCMV DNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-026 |
M |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-027 |
L |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-008 |
Mycoplasma pneumoniae DNA (MP DNA) liquid indoor quality NAT control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-009 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-010 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-319 |
Chlamydia pneumonia deoxyribonucleic acid (CP DNA) liquid indoor quality NAT control products |
L |
1.00E+03～1.00E+04 copies/mL
|
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-269 |
Humanmetapneumovirus RNA (HMPV RNA) Liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-270 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-271 |
L |
1.00E+03～1.00E+04 copies/mL
|
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-012 |
Gonococcal DNA (NGH DNA) liquid indoor quality NAT control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-013 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-014 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-022 |
Chlamydia trachomatis DNA (CT DNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-023 |
M |
1.00E+04～1.00E+05copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-024 |
L |
1.00E+03～1.00E+04copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-028 |
Ureaplasma urealyticum deoxyribonucleic acid (UU DNA) liquid indoor quality NAT control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-029 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-030 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-206 |
Ureaplasmamicrodeoxyribonucleic acid (UPDNA) liquid indoor quality NAT control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-207 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-208 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-113 |
Chlamydia trachomatis (CT), Ureaplasma urealyticum (UU), Neisseria gonorrhoeae (NGH) DNA liquid Mixed indoor quality NAT control products |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-114 |
L |
1.00E+04～1.00E+05 copies/mL
|
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-127 |
Mycoplasma hominisdeoxyribonucleic acid (MH DNA) liquid indoor quality NAT control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-128 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-129 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-133 |
Human papillomavirus typing deoxyribonucleic acid Indoor quality NAT control products |
M |
1.00E+05～1.00E+06 copies/mL
|
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-133-2 |
Human papillomavirus deoxyribonucleic acid (HPV DNA) mixed quality NAT control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-133-1 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-133-3 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-016 |
Human papillomavirus type 16 DNA (HPV16 DNA) liquid indoor quality NAT control products |
H |
1.00E+06～1.00E+07 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-017 |
M |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-018 |
L |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-019 |
Human papillomavirus type 18 DNA (HPV18 DNA) liquid indoor quality NAT control products |
H |
1.00E+06～1.00E+07 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-020 |
M |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-021 |
L |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-037 |
Human papillomavirus types 16 and 18 deoxyribose nuclei Acid liquid indoor quality NAT control products |
H |
1.00E+06～1.00E+07 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-038 |
M |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-039 |
L |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-041 |
Human papillomavirus type 6 deoxyribonucleic acid Indoor quality NAT control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-042 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-043 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-044 |
Human papillomavirus type 11 deoxyribonucleic acid Indoor quality NAT control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-045 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-046 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-047 |
Human papillomavirus type 6, 11 DNA Liquid indoor quality NAT control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-048 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-049 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-031 |
Herpes simplex virus type I DNA (HSV I DNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-032 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-033 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-034 |
Herpes simplex virus type II DNA (HSVⅡ DNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-035 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-036 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-321 |
Chickenpox - herpes zoster virus DNA (VZV DNA) liquid indoor quality NAT control products |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-163 |
B group Streptococcus deoxyribonucleic acid (GBS DNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-164 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-165 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-060 |
Mycobacterium tuberculosis deoxyribonucleic acid (TB DNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-059 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-058 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-063 |
Rubella virus RNA (RV RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-062 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-061 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-390 |
Measles virus RNA indoor quality NAT control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-260 |
Rubella/measles virus ribonucleic acid mixed liquid chamber Internal quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-261 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-262 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-064 |
Enterovirus 71 RNA (EV71 RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-065 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-066 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-115 |
Enterovirus universal ribonucleic acid (EV RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-116 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-117 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-067 |
Coxsackie virus CA16 RNA (CA16 RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-068 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-069 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-217 |
Coxsackie virus CA6 RNA (CA6 RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-218 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-219 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-220 |
Coxsackie virus CA10 RNA (CA10 RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-221 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-222 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-070 |
Group A rotavirus RNA (RWA RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-071 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-072 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-226 |
Norovirus RNA (NV RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-227 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-228 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-130 |
Influenza A virus RNA (IVA RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-131 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-132 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-073 |
Influenza B virus ribonucleic acid (IVB RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-074 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-075 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-316 |
Type B fluid-sensitive nucleotide nucleoacid (IVB RNA) liquid indoor quality NAT control products (Yamagata Plant) |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-317 |
Type B fluid-sensitive nucleotide nucleoacid (IVB RNA) Liquid indoor quality NAT control products (Victoria Plant) |
L |
1.00E+03～1.00E+04 copies/mL
|
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-173 |
Influenza A/HIN1 viral RNA (HIN1 RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-174 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-175 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-341 |
Influenza A H3N2 viral RNA (H3N2 RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-342 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-315 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-176 |
Influenza A H5N1 viral RNA (H5N1 RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-177 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-178 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-179 |
Influenza A (H7N9) virus RNA (H7N9) RNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-180 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-181 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-182 |
Influenza A H9N2 viral RNA (H9N2 RNA) liquid indoor quality NAT control products
|
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-183 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-184 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-281 |
Influenza A H9N2 viral RNA (H9N2 RNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-282 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-077 |
Human parainfluenza type 2 virus RNA (PIV2 RNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-078 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-080 |
Human parainfluenza 3 virus ribonucleic acid (PIV3 RNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-081 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-083 |
Human parainfluenza 4b virus RNA (PIV4b RNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-084 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-086 |
Respiratory syncytial virus type A RNA liquid Indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-087 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-230 |
Respiratory syncytial virus B RNA liquid Indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-231 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-233 |
Adenovirus DNA (ADV DNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-234 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-286 |
Adenovirus type 1 deoxyribonucleic acid (ADV1 DNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-287 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-288 |
Adenovirus type 2 deoxyribonucleic acid (ADV2 DNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-289 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-264 |
Adenovirus type 3 deoxyribonucleic acid (ADV3 DNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-265 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-278 |
Adenovirus type 4 deoxyribonucleic acid (ADV4DNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-279 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-290 |
Adenovirus type 5 deoxyribonucleic acid (ADV5DNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-291 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-267 |
Adenovirus type 7 deoxyribonucleic acid (ADV7 DNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-268 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-292 |
Adenovirus type 11 deoxyribonucleic acid (ADV11 DNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-293 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-294 |
Adenovirus type 14 deoxyribonucleic acid (ADV14 DNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-295 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-296 |
Adenovirus type 21 deoxyribonucleic acid (ADV21 DNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-297 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-298 |
Adenovirus type 41 deoxyribonucleic acid (ADV41 DNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-299 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-300 |
Adenovirus type 48 deoxyribonucleic acid (ADV48 DNA) liquid indoor quality NAT control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-301 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-088 |
Dengue virus type I RNA Liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-089 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-090 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-091 |
Dengue virus type II RNA Liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-092 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-093 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-094 |
Dengue virus type III RNA Liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-095 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-096 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-097 |
Dengue virus type IV RNA Liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-098 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-099 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-235 |
Human coronavirus HCoV-OC43 RNA Liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-236 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-237 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-238 |
Human coronavirus HCoV-HKU1 RNA Liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-239 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-240 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-241 |
Human coronavirus HCoV-229E RNA Liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-242 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-243 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-244 |
Human coronavirus HCoV-NL63 RNA Liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-245 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-246 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-247 |
Severe Acute respiratory syndrome coronavirus ribose Nucleic acid (SARS-CoV RNA) liquid chamber Quality NAT control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-248 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-249 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-275 |
2019 Novel coronavirus RNA (2019-nCoV RNA) liquid indoor quality NAT control product |
M S2 |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-276 |
L S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-304 |
S0 |
1.00E+02～1.00E+03 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-305 |
L1 |
500copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-367 |
L2 |
250copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-303 |
Negative |
/ |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-306 |
Novel coronavirus B.1.1.7 mutant nucleoacidIndoor quality NAT control products |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-306-1 |
Nucleoacid of novel coronavirus B.1.351 mutant strain Body NAT control product |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-306-2 |
Nuclear acid constitution of novel coronavirus P.1 mutant strain NAT control products |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-306-3 |
Nucleoacid of novel coronavirus B.1.617 mutant strain Body NAT control product |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-306-4 |
Nucleic acid of Omicron mutant strain of novel coronavirus Liquid quality NAT control products |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-306-5 |
Nucleic acid liquid of novel coronavirus Delta mutant strain Quality NAT control product |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-306-6 |
Mutations in the Omicron BA.2 subtype of the novel coronavirus Nucleic acid liquid quality NAT control products |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-373 |
Monkeypox virus deoxyribonucleic acid liquid indoor quality NAT control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,10 tubes/kit |
|
GBDS-IQC-374 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,10 tubes/kit |
|
|
GBDS-IQC-375 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,10 tubes/kit |
|
GBDS-IQC-383 |
Vaccinia virus nucleic acid indoor quality NAT control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-384 |
Vaccinia virus - Tiantan strain nucleic acid indoor quality NAT control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-385 |
Camel pox virus nucleic acid indoor quality NAT control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-386 |
Vaccinia virus nucleic acid indoor quality NAT control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-387 |
Light smallpox virus nucleic acid indoor quality NAT control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-388 |
Smallpox virus nucleic acid indoor quality NAT control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-389 |
Heavy smallpox virus nucleic acid indoor quality NAT control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-198 |
Middle East Respiratory Syndrome coronavirus (MERS) nuclear Sugar nucleic acid liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-199 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-200 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-255 |
Zika virus RNA liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-256 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-257 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-318 |
Human rhinovirus RNA (HRV RNA) solution Indoor quality NAT control products |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-343 |
Legionella pneumophila DNA liquid chamber Quality NAT control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-344 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-320 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-345 |
Staphylococcus aureus deoxyribonucleic acid (SA DNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-346 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-322 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-347 |
Candida albicans DNA liquid chamber Quality NAT control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-348 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-323 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-349 |
Candida albicans deoxyribonucleic acid (CG DNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-350 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-324 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-351 |
Pertussis bacteria deoxyribonucleic acid liquid chamber Quality NAT control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-352 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-325 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-353 |
Klebsiella pneumoniae deoxyribonucleic acid (KP DNA) liquid indoor quality NAT control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-354 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-326 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-355 |
Pneumococcal DNA liquid chamber Quality NAT control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-356 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-327 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-357 |
The internal deplasticized oxygen NAT control nucleosaccharide nucleic acid liquid chamber of Streptococcus pyogenes |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-358 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-328 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-359 |
Haemophilus influenzae deoxyribonucleic acid liquid indoor quality NAT control |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-360 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-329 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-361 |
Escherichia coli deoxynucleated sugar NAT control product nucleic acid liquid indoor quality |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-362 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-331 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-363 |
Listeria deoxynucleated sugar NAT control product nucleic acid liquid indoor quality |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-364 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-332 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-365 |
Salmonella deoxynucleated sugar NAT control nucleic acid liquid indoor substance |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-366 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-333 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-376 |
Helicobacter pylori DNA liquid chamber Quality NAT control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-377 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-378 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-379 |
Pseudomonas aeruginosa DNA liquid chamber Quality NAT control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-380 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-381 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-IQC-054 |
α Genetic diagnosis of thalassemia Positive quality NAT control products |
Optional genotypes |
-α 3.7 /αα；-α 4.2 /αα； -SEA/αα；-SEA/-α 3.7； -SEA/-α 4.2；-α 3.7 /-α 4.2, etc. |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-055 |
β Genetic diagnosis of thalassemia Positive quality NAT control products |
Optional genotypes |
β -28 /β N； β CD17 /β N；β CD41-42 /β N；β IVS-2-654 /β N；β CD26 /β N；etc. |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-056 |
α / β Thalassemia gene diagnosis normal quality NAT control products |
Normal person |
Whole blood, αα/αα; β / β |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-100 |
Noninvasive prenatal genetic testing: 21, 13, 18 Quality NAT control for liquid with abnormal number of chromophores |
21, 13, 18 staining trisomy |
21, 13, 18 staining trisomy |
0.7mL/ tube,10 tubes/kit |
|
GBDS-IQC-101 |
Noninvasive prenatal genetic testing: 21, 13, 18 Number of normal liquid quality NAT control products |
Normal quality NAT control product |
Different chromosomes are optional |
0.7mL/ tube,10 tubes/kit |
|
GBDS-IQC-254 |
Deafness gene dry blood spot (DBS) quality NAT control products |
Dry blood spot |
12 genes for deafness |
6 Blood spots/kit |
|
GBDS-IQC-382 |
Metagenomic sequencing quality NAT control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
1ml/tube，5 tube/kit |
|
GBDS-IQC-103 |
CYP2C19 gene test quality NAT control product |
Liquid |
CYP2C19*2、CYP2C19*3、CYP2C19*17 |
5 tube/kit |
|
GBDS-IQC-104 |
Folate metabolic capacity (MTHFR) Genotyping whole blood quality NAT control product |
Optional genotypes |
MTHFR Gene |
5 tube/kit |
|
GBDS-IQC-105 |
CYP3A5 gene test quality NAT control product |
Liquid |
CYP3A5 gene |
5 tube/kit |
|
GBDS-IQC-106 |
ROS1 gene test quality NAT control product |
Liquid |
ROS1 gene |
5 tube/kit |
|
GBDS-IQC-107 |
PIK3CAGene mutation quality NAT control products |
Liquid |
PIK3CA gene mutation |
5 tube/kit |
|
GBDS-IQC-108 |
EGFR Gene mutation quality NAT control products |
Liquid |
EGFR gene mutation |
5 tube/kit |
|
GBDS-IQC-109 |
KRAS gene mutation quality NAT control products |
Liquid |
KRAS gene mutation |
5 tube/kit |
|
GBDS-IQC-110 |
BRAF gene mutation quality NAT control products |
Liquid |
BRAF gene mutation |
5 tube/kit |
|
GBDS-IQC-302 |
ALK gene mutation quality NAT control products |
Liquid |
ALK gene mutation |
5 tube/kit |
|
GBDS-IQC-201 |
BRCA gene mutation quality NAT control products |
Liquid |
BRCA gene mutation |
5 tube/kit |
|
GBDS-IQC-202 |
TP53 gene mutation quality NAT control products |
Liquid |
TP53 gene mutation |
5 tube/kit |
|
GBDS-IQC-111 |
CYP2C9 and VKORC1 gene detection of warfarin Test quality NAT control products |
Liquid |
CYP2C9 and VKORC1 gene |
5 tube/kit |
|
GBDS-IQC-147 |
Phenylketonuria gene dry blood spot (DBS) quality NAT control product |
Dry blood spot |
4r kinds of PAH genes |
6 Blood spots/kit |
|
GBDS-IQC-258 |
Human acetaldehyde dehydrogenase 2(ALDH2) gene is abundant State test quality NAT control products |
Liquid |
ALDH2; c.1510G/A, heterozygous mutation |
5 tube/kit |
|
GBDS-IQC-259 |
Polypeptide of human SLCO1B1 and ApoE genes Check quality NAT control products |
Liquid |
SLCO1B1*1b，SLCO1B1*5、 ApoE2、ApoE4 |
5 tube/kit |
|
GBDS-IQC-203 |
Human HLA-B27 gene whole blood quality NAT control product |
Whole blood |
HLA-B27 Positive |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-204 |
Leukemia AML1-ETO fusion gene quality NAT control products |
Liquid |
AML1-ETO fusion |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-205 |
Leukemia PML-RARA fusion gene quality NAT control product |
Liquid |
PML-RARA fusion |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-251 |
Leukemia BCR-ABL1 fusion gene quality NAT control product |
Liquid |
BCR-ABL1 fusion |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-285 |
Serum/plasma negative quality NAT control products |
Negative |
Suitable for HBV DNA/HCV RNA/HIV1 RNA/TP DNA and other serum varieties were negative Quality NAT control |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-161 |
Negative quality NAT control products |
Negative |
Applicable to UU DNA/CT DNA/ NGH Negative quality NAT control of DNA and other cultured varieties |
0.5mL/ tube,20 tubes/kit |
|
GBDS-IQC-151-1 |
HPV negative quality NAT control products |
Negative |
It is suitable for the negative nature of all types of human papilloma NAT control; Human genome containing |
0.5mL/ tube,20 tubes/kit |
2. Immune indoor quality NAT control products
|
Number |
Name |
Concentration Serial |
Standard Value |
Specification |
|
GBDS-I-217 |
Novel Coronavirus (SARS-CoV-2) Antigen quality NAT control products |
/ |
Positive |
0.5mL/ tube,20 tubes/kit |
|
GBDS-I-218 |
Novel Coronavirus (SARS-CoV-2) IgG/IgM antibody quality NAT control product |
/ |
Positive |
0.5mL/ tube,20 tubes/kit |
|
GBDS-I-001 |
Hepatitis B virus surface antigen (HBsAg) serum (liquid) indoor Quality NAT control product |
S1 |
0.1 IU/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-I-002 |
S2 |
0.2 IU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-003 |
S3 |
0.5 IU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-004 |
S4 |
5.0 IU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-005 |
S5 |
25.0 IU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-006 |
Hepatitis B virus surface antibody (HBsAb) serum (liquid) indoor Quality NAT control product |
S1 |
5 IU/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-I-007 |
S2 |
10 IU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-008 |
S3 |
25 IU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-009 |
S4 |
50 IU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-010 |
S5 |
100 IU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-011 |
Hepatitis B virus e antigen (HBeAg) serum (liquid) indoor Quality NAT control product |
S1 |
1.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-I-012 |
S2 |
2.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-013 |
S3 |
4.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-014 |
Hepatitis B virus e antibody (HBeAb) serum (liquid) indoor Quality NAT control product |
S1 |
1.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-I-015 |
S2 |
2.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-016 |
S3 |
4.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-017 |
S4 |
8.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-018 |
Hepatitis B virus core antibody (HBcAb) serum (liquid) indoor Quality NAT control product |
S1 |
0.5 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-I-019 |
S2 |
1.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-020 |
S3 |
1.5 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-021 |
S4 |
2.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-036 |
Human immunodeficiency virus Type 1 antibody (anti-HIV-1) Serum (liquid) indoor quality NAT control products |
L1 |
0.2 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-I-035 |
S0 |
0.5 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-022 |
S1 |
1.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-023 |
S2 |
2.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-024 |
S3 |
4.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-025 |
S4 |
8.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-219 |
Antibodies to hepatitis C virus (anti-HCV) serum (fluid) chamber Internal quality NAT control products |
L2 |
0.03 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
GBDS-I-220 |
L1 |
0.05 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-034 |
S0 |
0.5 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-026 |
S1 |
1.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-027 |
S2 |
2.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-028 |
S3 |
4.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-029 |
S4 |
8.0 NCU/mL |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-030 |
Antibody to Treponema pallidum (anti-TP) Serum (liquid) indoor quality NAT control products |
S1 |
3.0 mIU/ml |
0.5mL/ tube,20 tubes/kit |
|
GBDS-I-031 |
S2 |
6.0 mIU/ml |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-032 |
S3 |
12 mIU/ml |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-033 |
S4 |
18 mIU/ml |
0.5mL/ tube,20 tubes/kit |
|
|
GBDS-I-133 |
Prenatal screening indoor quality NAT control products |
S1 |
L |
1.0mL/ bottle, 9 bottles/kit |
|
GBDS-I-134 |
S2 |
M |
1.0mL/ bottle, 9 bottles/kit |
|
|
GBDS-I-135 |
S3 |
H |
1.0mL/ bottle, 9 bottles/kit |
|
|
GBDS-I-136 |
Neonatal screening indoor quality NAT control products |
S1 |
L |
2 blood spots/set, 3 sets/kit |
|
GBDS-I-137 |
S2 |
M |
（1）G6PD blood spot （2）TSH\Phe\17-OHP |
|
|
GBDS-I-213 |
S3 |
H |
||
|
GBDS-I-152 |
A variety of amino acids, carnitine and succinylpropyl Ketone indoor quality NAT control products |
C1 |
L |
There were 5 blood spots in C1 and C2 respectively, 10 Blood spot/set, 1 set/kit |
|
C2 |
H |
|||
|
GBDS-I-210 |
Indoor quality NAT control product for immune serum (dry powder) |
S1 |
L |
5.0mL/ bottle, 6 bottles/kit |
|
GBDS-I-211 |
S2 |
M |
5.0mL/ bottle, 6 bottles/kit |
|
|
GBDS-I-212 |
S3 |
H |
5.0mL/ bottle, 6 bottles/kit |